REDWOOD CITY, Calif.,
Nov. 5, 2019 /PRNewswire/
-- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty
pharmaceutical company focused on the development and
commercialization of innovative therapies for the use in medically
supervised settings, today announced that management will be
presenting at the Credit Suisse 28th Annual Healthcare
Conference to be held November 11
– 13. AcelRx management will provide an overview of the
business and company updates during the live presentation and will
be available for one-on-one meetings with investors.
Details of the event are as follows:
Credit Suisse 28th Annual Healthcare Conference
Date:
Wednesday, November 13, 2019
Location: The Phoenician, Scottsdale,
AZ
Presentation Time: 9:10 am local time
(11:10 a.m. ET)
The conference will be webcast live and can be accessed through
the Investors page at www.acelrx.com. For those not available to
listen to the live broadcast, a replay will be archived for 90 days
and available through the Investors page on www.acelrx.com.
About AcelRx Pharmaceuticals, Inc.
AcelRx
Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of innovative therapies
for use in medically supervised settings. AcelRx's proprietary,
non-invasive sublingual formulation technology delivers sufentanil
with consistent pharmacokinetic profiles. The Company has one
approved product in the U.S., DSUVIA® (sufentanil sublingual
tablet, 30 mcg), known as DZUVEO in Europe, indicated for the management of acute
pain severe enough to require an opioid analgesic for adult
patients in certified medically supervised healthcare settings, and
one product candidate, Zalviso® (sufentanil sublingual tablet
system, SST system, 15 mcg) being developed as an innovatively
designed patient-controlled analgesia (PCA) system for reduction of
moderate-to-severe acute pain in medically supervised settings.
DZUVEO and Zalviso are both approved products in Europe. Zalviso is not approved in the U.S.
For additional information about AcelRx, please visit
www.acelrx.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-to-present-at-credit-suisse-28th-annual-healthcare-conference-300952174.html
SOURCE AcelRx Pharmaceuticals, Inc.